Menu Back to Meeting-Details

DIA Europe 2021 Call for Poster Abstracts

3/17/2021 7:00:00 AM - 3/19/2021 3:00:00 PM


Abstract submission deadline
Thursday, 1 October 2020, 23:59 CET

General Submission Requirements

Please read the following instructions carefully, as incorrect or incomplete abstracts will not be considered.

  • All abstracts must be submitted online at DIAglobal.org/Abstracts.
  • The title must reflect the abstract content accurately and concisely.
  • All poster presentations must be non-commercial and scientific in nature and may not be used as a marketing opportunity. Any mention of specific products or and/or services must be limited to generic names, with no inclusion of brand names in any area of the poster, including poster titles and/or handouts. Logos and advertising may not appear anywhere on the poster.
  • Posters must be original in research and include appropriate empirical evidence.
  • Posters must include data, i.e., research results and conclusion, Preliminary/pilot data is acceptable.
  • Only one author is to be identified at the time of submitting.

Submission Topics

1) Clinical Development
2) Clinical Operations
3) CMC, Quality, GMP
4) Health Policy
5) Regional Updates
6) Regulatory Operations
7) Regulatory Strategy
8) Safety and PV
9) Value and Access

Abstract Structure and Guidelines

  • Abstract Title - Maximum 125 characters including spaces. Titles should briefly describe the focus of the abstract as well as accurately reflect the content of the abstract.
  • Interest Area/Track - Select the interest area that suits your poster’s subject/topic.
  • Keywords - Maximum 100 characters including spaces. Please provide 1 or more keywords associated with your abstract. These may be used for search purposes should your abstract be selected as a concept. Examples of keywords: Personalised Medicine, Health Technology Assessment, Clinical Trial Agreements.
  • Objective - Maximum 300 characters including spaces. Please provide a one-sentence statement of the objective of the abstract.
  • Method - Maximum 300 characters including spaces. When, where, and how was the study was done? What materials were used or who was included in the study?
  • Results - Maximum 2000 characters including spaces. What quantitative data was collected; what answer was found to the research question; what did the study find? Was the tested hypothesis true?
  • Conclusion - Maximum 2000 characters including spaces. State what can be concluded from the study and its implications.

Notification Date
Submitters will be notified of the status of each abstract no later than the week ending October 9, 2020.

Assistance needed
Please contact: DIAEuropeProgram@diaglobal.org